Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

Mario I Vega, PhD, Alberto Valencia-Hipolito, MD/PhD, Miriam Hernandez-Atenogenes, ChB, Gabriel G Vega, MDVZ/PhD, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, Ph.D, Otoniel Martinez-Maza, PhD

Blood (2013) 122 (21): 3004.

https://doi.org/10.1182/blood.V122.21.3004.3004

Published: 2013

Journal Articles

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Ran Halleluyan, Joseph Ben-Zvi, Mitchell Song, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 5362.

https://doi.org/10.1182/blood.V122.21.5362.5362

Published: 2013

Journal Articles

Decreased LIMD1 Gene Expression Is Associated with HIF-1α Over-Expression and Angiogenesis in Multiple Myeloma

Haiming Chen, MD., Ph.D, Jennifer Li, Kevin Delijani, Danielle Rauch, Kevin DeCorso, Andrew Prajogi, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 1829.

https://doi.org/10.1182/blood.V120.21.1829.1829

Published: 2012

Journal Articles

Inhibition of B-NHL Tumor Xenografts Following Treatment with Galiximab (Anti-CD80 mAb) and Potentiation When Combined with Chemotherapy

Mario I Vega, PhD, Hari Hariharan, PhD, Peter Chu, PhD, Tracey Murphy, PhD, Dana Clanton, PhD, Lisa Berquist, PhD, Arturo Molina, PhD, Steffan Ho, PhD, Benjamin Bonavida, Ph.D

Blood (2012) 120 (21): 4873.

https://doi.org/10.1182/blood.V120.21.4873.4873

Published: 2012

Journal Articles

Anti-Myeloma Effects of the Janus Kinase 2 (JAK2) Inhibitor SAR503 Alone and in Combination Treatment

Haiming Chen, MD., Ph.D, Mingjie Li, Jennifer Li, Kevin Delijani, Danielle Rauch, Kevin DeCorso, Andrew Prajogi, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 4986.

https://doi.org/10.1182/blood.V120.21.4986.4986

Published: 2012

Journal Articles

Unresponsiveness to CHOP Is Associated with Activation of the p38 MAPK Pathway in Patients with DLBCL

Mario I Vega, PhD, Alejandro Aviles-Salas, MD, J Ramon Chalapud, MD, Sara Huerta-Yepez, PhD, Rogelio Hernandez-Pando, MD, PhD, Melisa Martinez-Paniagua, BSc, MSc, Bernardo Martinez-Miguel, BCh, Miriam Hernandez-Atenogenes, ChB, Gabriel G Vega, MDVZ, Haiming Chen, James R. Berenson, MD, Hector Mayani, PhD, Otoniel Martinez-Maza, PhD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 2647.

https://doi.org/10.1182/blood.V118.21.2647.2647

Published: 2011

Journal Articles

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Hong Liu, Sara Huerta-Yepez, Ph.D, Clara M. Rivera-Pazos, MD, Ma de Lourdes Cabera-Muñoz, MD, Stavroula Baritaki, Ph.D, Suzie Vardanyan, Manuel L Penichet, M.D., Ph.D., Haiming Chen, James R. Berenson, MD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3991.

https://doi.org/10.1182/blood.V118.21.3991.3991

Published: 2011

Journal Articles

Autoantibodies Directed Against Moesin C 471-577 /N 1-297 Are Novel and Specific Biomarkers of Immune Thrombocytopenic Purpura (ITP),

Yue Zhang, Hua Mao, Aimin Zhao, Feng Du, Xiaofang Liu, Shou Zhinan, Hongbin Sun, Chengxiu Gao, Yongjun Han, Weina Situ, Lei Sheng, Jie Qian, Yang Jian, Yong Xu, Jia Wei, Benjamin Bonavida, Ph.D, Haiming Chen

Blood (2011) 118 (21): 3301.

https://doi.org/10.1182/blood.V118.21.3301.3301

Published: 2011

Journal Articles

Co-Overexpression of YY1 and Gp-170 (MDR1) in Childhood Acute Lymphocytic Leukemia (ALL): Transcription Regulation of Gp-170 by YY1 and Prognostic Significance,

Gabriela andres-Antonio, Jesus Rangel-Santiago, B.S., Ana B Tirado-Rodriguez, B.S., Elisa Dorantes-Acosta, MD MSc, Mario I Vega, PhD, Guillermo Aquino-Jarquin, PhD, Briseida Lopez, MD, Elba Jimenez, MD, Rosana Pelayo, PhD, Benjamin Bonavida, Ph.D, Aurora Medina-Sanson, MD, Sara Huerta-Yepez, PhD

Blood (2011) 118 (21): 3567.

https://doi.org/10.1182/blood.V118.21.3567.3567

Published: 2011

Journal Articles

Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy,

Gabriel G Vega, MDVZ, Mario I Vega, PhD, Sara Huerta-Yepez, Ph.D., Ali Jazirehi, PhD, Hector Mayani, PhD, Otoniel Martinez-Maza, PhD, Sherie Morrison, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3499.

https://doi.org/10.1182/blood.V118.21.3499.3499

Published: 2011

Journal Articles

Blockage of CGEN-928 Expression Down-Regulates AKT Signaling Pathway and Inhibits Multiple Myeloma (MM) Cell Proliferation

Haiming Chen, Mingjie Li, Jennifer Li, Marissa P Dreyer, Cameryn P Ahles, Tiffany Lee, Joleen T Qiu, Cathy Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, Ofer Levy, Liat Dassa, Gady Cojocaru, Zurit Levine, James R. Berenson, MD

Blood (2011) 118 (21): 5102.

https://doi.org/10.1182/blood.V118.21.5102.5102

Published: 2011

Journal Articles

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Jennifer Li, Andrew Leu, Mingjie Li, Ethan D Hobel, Kevin Delijani, Joleen T Qiu, David Ramirez, Alison C Lam, Cathy Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 2917.

https://doi.org/10.1182/blood.V118.21.2917.2917

Published: 2011

Journal Articles

TRAF6 Dominant Negative Peptides Block Intracellular Signaling Resulting in Anti-Myeloma and Anti-Bone Resorptive Effects in Multiple Myeloma

Mingjie Li, Marissa P Dreyer, Cameryn P Ahles, David Ramirez, Cydney M Nichols, Tiffany Lee, More Song, Cathy S Wang, Eric Sanchez, Haiming Chen, Benjamin Bonavida, Ph.D, James R. Berenson, MD

Blood (2011) 118 (21): 2919.

https://doi.org/10.1182/blood.V118.21.2919.2919

Published: 2011

Journal Articles

Upregulation of KLF4 Expression in Pediatric B-NHL Lymphomas and Its Association with Low EFS and Poor Survival Following Treatment with Chemotherapy

Mario I Vega, PhD, Miriam Hernandez-Atenogenes, ChB, Alberto Valencia, MD, Gabriel G Vega, MDVZ, Altagracia Maldonado-Valenzuela, ChB, Guillermo Ramon, MD, Haiming Chen, James R. Berenson, MD, Otoniel Martinez-Maza, PhD, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 5184.

https://doi.org/10.1182/blood.V118.21.5184.5184

Published: 2011

Journal Articles

The Overexpression of Inactive Phosphorylated Raf-1 Kinase Inhibitory Protein (RKIP) in Multiple Myeloma (MM) Regulates the Resistance to Bortezomib-Induced Cytotoxicity: Reversal of Resistance by the PKC Inhibitor Bisindolylmalemide

Sara Huerta-Yepez, PhD, Stavroula Baritaki, PhD, Hong Liu, Karla MC Mendez-Maldonado, B.S., Manuel L Penichet, M.D., Ph.D., Mario I Vega, PhD, Otoniel Martinez-Maza, PhD, Haiming Chen, James R. Berenson, MD, Devasis Chatterjee, PhD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 2892.

https://doi.org/10.1182/blood.V118.21.2892.2892

Published: 2011

Journal Articles

The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.

Elizabeth Ortiz-Sanchez, PhD, Tracy R. Daniels, Ph.D., Gustavo Helguera, Ph.D., Otoniel Martinez-Maza, Ph.D., Benjamin Bonavida, Ph.D., Manuel L. Penichet, M.D., Ph.D.

Blood (2007) 110 (11): 4204.

https://doi.org/10.1182/blood.V110.11.4204.4204

Published: 2007

Journal Articles

Pleiotrophin Promotes Myeloma Proliferation through the Activation of Known and Novel Receptors.

Melinda S. Gordon, PhD, Hee Jin Lee, Richard A. Campbell, Charles B. Drucker, Matthew Katz, Richard K. Leuchter, Benjamin Bonavida, Ph.D., James R. Berenson, M.D.

Blood (2006) 108 (11): 4354.

https://doi.org/10.1182/blood.V108.11.4354.4354

Published: 2006

Journal Articles

2-Methoxyestradiol Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis Via Inhibition of HIF-1α, NF-κ B, YY1 and Induction of DR5 Expression.

Sara Huerta-Yepez, PhD, Mario I. Vega, Ph.D., Stavroula Baritaki, Ph.D., Eriko Suzuki, Theresa La Vallee, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 4642.

https://doi.org/10.1182/blood.V108.11.4642.4642

Published: 2006

Journal Articles

Nitric Oxide Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis through Induction of RKIP, Inhibition of YY1 and Upregulation of DR5.

Stavroula Baritaki, PhD, Alina Katsman, Sara Huerta-Yepez, Ph.D., Kam C. Yeung, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 4604.

https://doi.org/10.1182/blood.V108.11.4604.4604

Published: 2006

Journal Articles

Over Expression of YY1 and RKIP in Multiple Myeloma (Cell Lines and MM Tissues).

Stavroula Baritaki, PhD, Sara Huerta-Yepez, Ph.D., Alina Katsman, Kam C. Yeung, Ph.D., Devasis Chatterjee, Ph.D., Haiming Chen, Ph.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.

Blood (2006) 108 (11): 5035.

https://doi.org/10.1182/blood.V108.11.5035.5035

Published: 2006

NARROW

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Decreased LIMD1 Gene Expression Is Associated with HIF-1α Over-Expression and Angiogenesis in Multiple Myeloma

Inhibition of B-NHL Tumor Xenografts Following Treatment with Galiximab (Anti-CD80 mAb) and Potentiation When Combined with Chemotherapy

Anti-Myeloma Effects of the Janus Kinase 2 (JAK2) Inhibitor SAR503 Alone and in Combination Treatment

Unresponsiveness to CHOP Is Associated with Activation of the p38 MAPK Pathway in Patients with DLBCL

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Autoantibodies Directed Against Moesin C 471-577 /N 1-297 Are Novel and Specific Biomarkers of Immune Thrombocytopenic Purpura (ITP),

Co-Overexpression of YY1 and Gp-170 (MDR1) in Childhood Acute Lymphocytic Leukemia (ALL): Transcription Regulation of Gp-170 by YY1 and Prognostic Significance,

Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy,

Blockage of CGEN-928 Expression Down-Regulates AKT Signaling Pathway and Inhibits Multiple Myeloma (MM) Cell Proliferation

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

TRAF6 Dominant Negative Peptides Block Intracellular Signaling Resulting in Anti-Myeloma and Anti-Bone Resorptive Effects in Multiple Myeloma

Upregulation of KLF4 Expression in Pediatric B-NHL Lymphomas and Its Association with Low EFS and Poor Survival Following Treatment with Chemotherapy

The Overexpression of Inactive Phosphorylated Raf-1 Kinase Inhibitory Protein (RKIP) in Multiple Myeloma (MM) Regulates the Resistance to Bortezomib-Induced Cytotoxicity: Reversal of Resistance by the PKC Inhibitor Bisindolylmalemide

The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.

Pleiotrophin Promotes Myeloma Proliferation through the Activation of Known and Novel Receptors.

2-Methoxyestradiol Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis Via Inhibition of HIF-1α, NF-κ B, YY1 and Induction of DR5 Expression.

Nitric Oxide Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis through Induction of RKIP, Inhibition of YY1 and Upregulation of DR5.

Over Expression of YY1 and RKIP in Multiple Myeloma (Cell Lines and MM Tissues).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only